MINAPHARM Pharmaceuticals (EGX: MIPH)

Egypt flag Egypt · Delayed Price · Currency is EGP
161.54
-7.53 (-4.45%)
At close: Jan 28, 2025
-35.06%
Market Cap 1.79B
Revenue (ttm) 4.42B
Net Income (ttm) -190.31M
Shares Out 11.06M
EPS (ttm) -17.20
PE Ratio n/a
Forward PE n/a
Dividend 1.65 (0.98%)
Ex-Dividend Date May 8, 2024
Volume 1,928
Average Volume 2,032
Open 169.07
Previous Close 169.07
Day's Range 145.00 - 170.00
52-Week Range 145.01 - 294.70
Beta -0.04
RSI 40.73
Earnings Date Apr 8, 2025

About MINAPHARM Pharmaceuticals

MINAPHARM Pharmaceuticals produces medicines, medical and dental supplies, and dietary supplements in Egypt and internationally. The company produces veterinary and herbal medicines. It offers its products for the treatment of hematoma and thrombosis, iron deficiency anemia, recurrent urinary tract infections, immunostimulants, osteoporosis, renal osteodystrophy, loop diuretics, prophylaxis, hemorrhoids, rheumatoid arthritis, hyperlipidemia, alopecia, skin infections, topical corticosteroids, gynecological antifungals, vaginal infections, anti-... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 450
Stock Exchange Egyptian Stock Exchange
Ticker Symbol MIPH
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.